WINTON MATTHEW (COO) reported 1 transaction at INOZYME PHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/3/2025ACC: 0000950170-25-094098
-208.24K
Net shares
Net seller
$87.0K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
208.24K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−21.74K
Price / share
$4.00
Trade value
$86.97K
% of position
New position
7/1/2025
21.74K→0.00
Total
Net shares
−21.74K
Net value
-$86.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2025 | U · U | −21.74K | $4.00 | $86.97K | New position | 21.74K | 0.00 |
| Total | −21.74K | -$86.97K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
41.50K shares
Shares
−41.50K
Strike price
Held after
0.00
Exercisable
—
7/1/2025
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
145K shares
Shares
−145K
Strike price
1.06
Held after
0.00
Exercisable
—
7/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock41.50K shares | 7/1/2025 | D · Disposition | −41.50K | — | 0.00 | |
| Stock Option (Right to Buy) Direct | Common Stock145K shares | 7/1/2025 | D · Disposition | −145K | 1.06 | — | 0.00 |